Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond T P Lin

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Human Vaccines & Immunotherapeutics|May 5, 2026
NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variantsXuan Ying Poh, Shirley Y Y Mah, Aileen Y Y Yeoh, et al.
BMC Infectious Diseases|December 5, 2012
Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases - evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in SingaporeShu E Soh, Alex R Cook, Mark I C Chen, et al.
NPJ Digital Medicine|June 30, 2022
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimensAgata Blasiak, Anh T L Truong, Alexandria Remus, et al.
Scientific Reports|April 6, 2021
Clinical features and predictors of severity in COVID-19 patients with critical illness in SingaporeSer Hon Puah, Barnaby Edward Young, Po Ying Chia, et al.
Scientific Reports|November 7, 2023
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta waveYun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.
The New England Journal of Medicine|March 13, 2020
SARS-CoV-2 Infection among Travelers Returning from Wuhan, ChinaOon-Tek Ng, Kalisvar Marimuthu, Po-Ying Chia, et al.
Scientific Reports|January 17, 2024
Author Correction: Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta waveYun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.
Biopreservation and Biobanking|September 9, 2024
A Review of Regulatory Frameworks for Biobanking in Southeast AsiaPlebeian B Medina, Subasri Armon, Mohammad Firdaus Bin Abdul Aziz, et al.
Environmental Microbiology|March 27, 2019
The urgent need for microbiology literacy in societyKenneth Timmis, Ricardo Cavicchioli, José Luis Garcia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2022
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical TrialXuan Ying Poh, Chee Wah Tan, I Russel Lee, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Human Vaccines & Immunotherapeutics|May 5, 2026
NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variantsXuan Ying Poh, Shirley Y Y Mah, Aileen Y Y Yeoh, et al.
BMC Infectious Diseases|December 5, 2012
Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases - evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in SingaporeShu E Soh, Alex R Cook, Mark I C Chen, et al.
NPJ Digital Medicine|June 30, 2022
The IDentif.AI-x pandemic readiness platform: Rapid prioritization of optimized COVID-19 combination therapy regimensAgata Blasiak, Anh T L Truong, Alexandria Remus, et al.
Scientific Reports|April 6, 2021
Clinical features and predictors of severity in COVID-19 patients with critical illness in SingaporeSer Hon Puah, Barnaby Edward Young, Po Ying Chia, et al.
Scientific Reports|November 7, 2023
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta waveYun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.
The New England Journal of Medicine|March 13, 2020
SARS-CoV-2 Infection among Travelers Returning from Wuhan, ChinaOon-Tek Ng, Kalisvar Marimuthu, Po-Ying Chia, et al.
Scientific Reports|January 17, 2024
Author Correction: Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta waveYun Shan Goh, Siew-Wai Fong, Matthew Zirui Tay, et al.
Biopreservation and Biobanking|September 9, 2024
A Review of Regulatory Frameworks for Biobanking in Southeast AsiaPlebeian B Medina, Subasri Armon, Mohammad Firdaus Bin Abdul Aziz, et al.
Environmental Microbiology|March 27, 2019
The urgent need for microbiology literacy in societyKenneth Timmis, Ricardo Cavicchioli, José Luis Garcia, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 11, 2022
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical TrialXuan Ying Poh, Chee Wah Tan, I Russel Lee, et al.
Pageof 10